“…Among the remaining lncRNAs, CRNDE is one of the best studied oncogenic lncRNAs. In most cancer types, such as glioma, pancreatic cancer, cervical cancer, colorectal carcinoma, GC, clear cell renal cell carcinoma, and hepatocellular carcinoma, CRNDE can facilitate the proliferation, migration, invasion and metastasis of cancer cells, leading to a poor prognosis for patients with the above cancer types (Ding et al, 2018;Hu, Du, Zhang, & Huang, 2017;Jiang et al, 2017;Meng, Li, Li, & Ma, 2017;Tang, Zheng, & Zhang, 2018;G. Wang, Pan, Zhang, Wei, & Wang, 2017;Zheng et al, 2016).…”